This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about vendor vetting, and it is deliberately narrow — everything I am not confident about is marked as such.
What is actually established
The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.
The condition it depends on
One flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.
The practical version
Red flags, in rough order of how much they should worry you: no verifiable address, no batch numbers, prices far under market, vendor-commissioned tests only, pressure toward irreversible payment, and shipping with no temperature control.
What I am not sure about
What I actually want to know is how people are distinguishing a supplier having a bad batch from a supplier on the way out. I have searched first, so if this is covered somewhere point me at it and I will read it.
HealthEcon_DC said:The pattern that distinguishes a bad batch from an exit is behaviour rather than product.
No disagreement with HealthEcon_DC. One condition attached. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.
HealthEcon_DC said:The pattern that distinguishes a bad batch from an exit is behaviour rather than product.
I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTaking the question as asked, rather than the general version of it. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.